Table 2.
The PrevHPV study schedule of enrolment, intervention’s components and endpoints measurements
| 2021 | 2022 | 2023 | ||||||||||||||||||
| April | May | June | July | August | September | October | November | December | January | February | March | April | May | June | July | August | September | … | March | |
| Enrolment | ||||||||||||||||||||
| Assessment for municipality eligibility | ||||||||||||||||||||
| Randomisation (Group Allocation) | ||||||||||||||||||||
| GPs information and training proposal | ||||||||||||||||||||
| Parents and adolescents information about component(s) performed in their school | ||||||||||||||||||||
| Intervention components | ||||||||||||||||||||
| Adolescents and parents’ education and motivation (groups 1–4) |
|
|||||||||||||||||||
| GPs’ training (groups 1, 2, 5) |
|
|||||||||||||||||||
| HPV vaccination at school (groups 1, 3) |
|
|||||||||||||||||||
| Endpoints measurements | ||||||||||||||||||||
| HPV VC prevalence (groups 1–6) | ||||||||||||||||||||
| KABP-6C adolescents and parents (groups 1–6) | ||||||||||||||||||||
| KABP-6C GPs (groups 1, 2 and 5) | ||||||||||||||||||||
| Costs (groups 1–6) | ||||||||||||||||||||
| Implementation measures (groups 1–5) | ||||||||||||||||||||
GPs, general practitioners; HPV, human papillomavirus; KABP-6C, Knowledge, attitude, behaviours, practices and six psychological determinants of vaccination intention (Confidence, Complacency, Constraints, Calculation, Collective responsibility and social Conformism); VC, vaccine coverage.